Sialylation is involved in the development of MDR of AML cells likely through ST3GAL5 and ST8SIA4, with high expression of ST3GAL5 in drug-sensitive cells and high expression of ST8SIA4 in adriamycin-resistant cells. The gene discussed is ST8SIA4; the disease is acute myeloid leukemia.